Furthermore, the MCT inhibitor α-cyano-4-hydroxycinnamate (CHC) induced cytotoxic effects and inhibited proliferation, invasion, and migration capacity in high-grade glioma cell lines which possessed high expression of MCT1 [53,54]. Here, SLC16A1 is linked to central nervous system cancer.